BioTime, Inc. Press Releases

BTX 
$4.97
*  
0.03
0.6%
Get BTX Alerts
*Delayed - data as of Mar. 31, 2015  -  Find a broker to begin trading BTX now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    BTX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By





MSCI Named a Top 5 Risk Technology Firm in RiskTech100®
3/11/2015 8:00:00 AM - Business Wire












Navigators Launches International Casualty Unit
2/10/2015 3:00:00 PM - GlobeNewswire








BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy
1/26/2015 8:00:00 AM - Business Wire
▲28.09 % Price Change since this news event. The Volume Ratio is 2.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioTime Subsidiary OncoCyte Corporation Appoints William Annett to Its Board of Directors
1/12/2015 8:00:00 AM - Business Wire
▲17.49 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day